Paul Jai Sekhri is an American businessperson who founded Cerimon Pharmaceuticals, Inc. and who has been the head of 10 different companies. Currently, he holds the position of Chairman-Supervisory Board of Pharming Group NV, Chairman for Compugen Ltd., President, Chief Executive Officer & Director at eGenesis, Inc., President, Chief Executive Officer & Director at Lycera Corp. and Chairman for Pharming NV.
He is also Operating Partner at Highline Therapeutics, Inc., Member of Ontario Institute for Cancer Research, Member-Patrons Council at The Carnegie Hall Society, Inc. and Managing Director & Operating Partner at Tarrant Capital IP LLC and on the board of 15 other companies.
Mr. Sekhri previously held the position of Chairman of Petra Pharma Corp., Chairman of moksha8 Pharmaceuticals, Inc., Chairman at Topas Therapeutics GmbH, President & Chief Executive Officer of Cerimon Pharmaceuticals, Inc., Venture Partner at Mpm Capital LLC, Partner-Healthcare Investments at New Leaf Venture Partners LLC, Chief Strategy Officer & EVP-Business Development at Teva Pharmaceutical Industries Ltd., President & Chief Business Officer at ARIAD Pharmaceuticals, Inc., Partner at Sprout Group, Senior Vice President-Integrated Care at Sanofi, Inc., Operating Partner & Head-Biotechnology Operations at TPG Biotech Equity LP, Senior VP, Head-Global Search & Evaluation at Novartis Pharma AG and Senior Vice President-Integrated Care at Sanofi SA.
Mr. Sekhri received a graduate degree and an undergraduate degree from the University of Maryland School of Medicine and an undergraduate degree from the University of Maryland.